|
95
|
241
|
6t4gA |
Ror(gamma)t ligand binding domain in complex with cholesterol and allosteric ligand fm26 |
|
94
|
240
|
6tlqA |
Ror(gamma)t ligand binding domain in complex with cholesterol and allosteric ligand glenmark |
|
117
|
319
|
6tfiA |
Pxr in complex with thrombin inhibitor compound 17 |
|
83
|
250
|
6zosA |
Oestrogen receptor ligand binding domain in complex with compound 18 |
|
96
|
265
|
7kxdA |
Crystal structure of rar-related orphan receptor c (nhis-rorgt(244-487)-l6-src1(678-692)) in complex with {3,5-dichloro-4-[4-methoxy-3-(propan-2-yl)phenoxy]phenyl}methanol |
|
97
|
265
|
7kxfA |
Crystal structure of rar-related orphan receptor c (nhis-rorgt(244-487)-l6-src1(678-692)) in complex with {3,5-dichloro-4-[4-methoxy-3-(propan-2-yl)phenoxy]phenyl}methanol |
|
83
|
250
|
6zoqA |
Oestrogen receptor ligand binding domain in complex with compound 16 |
|
94
|
250
|
7c7vA |
Vitamin d3 receptor/lithochoric acid derivative complex |
|
82
|
250
|
6zorA |
Oestrogen receptor ligand binding domain in complex with compound 28 |
|
88
|
251
|
7c7wA |
Vitamin d3 receptor/lithochoric acid derivative complex |
|
100
|
265
|
7kxeA |
Crystal structure of rar-related orphan receptor c (nhis-rorgt(244-487)-l6-src1(678-692)) in complex with {3,5-dichloro-4-[4-methoxy-3-(propan-2-yl)phenoxy]phenyl}methanol |
|
79
|
222
|
6ln4A |
Estrogen-related receptor beta(err2) in complex with pgc1a-2a |
|
80
|
198
|
6litA |
Estrogen-related receptor beta(err2) in complex with bpa |
|
87
|
299
|
6t2mA |
Vdr-zk168281 complex |
|
83
|
213
|
7jh2A |
Crystal structure of rar-related orphan receptor c in complex with a potent, selective and orally bioavailable ror-gamma-t inverse agonist |
|
80
|
221
|
6xfvA |
Crystal structure of rar-related orphan receptor c in complex with a novel inverse agonist |
|
82
|
222
|
6knrA |
Crystal structure of estrogen-related receptor gamma ligand-binding domain with dn200699 |
|
99
|
263
|
6kxxA |
Human ppar alpha ligand binding domain in complex with a synthetic agonist (compound a) |
|
102
|
263
|
6kxyA |
Human ppar alpha ligand binding domain in complex with a synthetic agonist (compound b) |
|
76
|
259
|
6k9mA |
Human lxr-beta in complex with an agonist |
|
86
|
227
|
6k3nA |
Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with bpa-monof |
|
92
|
265
|
6xaeA |
Substituted benzyloxytricyclic compounds as retinoic acid-related orphan receptor gamma t agonists |
|
84
|
240
|
6wokA |
Crystal structure of estrogen receptor alpha in complex with receptor degrader 6 |
|
85
|
228
|
6vswA |
Optimization and biological evaluation of thiazole-bis-amide inverse agonists of rorgt |
|
87
|
238
|
6vifA |
Human lrh-1 ligand-binding domain bound to agonist cpd 15 and fragment of coregulator tif-2 |
|
99
|
273
|
6tsgA |
Crystal structure of peroxisome proliferator-activated receptor gamma (pparg) in complex with tetrac |
|
98
|
265
|
6u25A |
Crystal structure of rar-related orphan receptor c (nhis- rorgt(244-487)-l6-src1(678-692)) in complex with a tricyclic inverse agonist |
|
84
|
250
|
6suoA |
Era_l536s (l536s/c381s/c471s,c530s) in complex with a tricyclic indole (compound 6) |
|
91
|
270
|
6o68A |
Crystal structure of human ppargamma ligand binding domain in complex with ciglitazone |
|
101
|
273
|
6k0tA |
Crystal structure of ppargamma ligand binding domain in complex with dibenzooxepine derivative compound-17 |
|
90
|
259
|
6nwuA |
Rorgamma ligand binding domain |
|
94
|
259
|
6nwsA |
Rorgamma ligand binding domain |
|
91
|
233
|
6nwtA |
Rorgamma ligand binding domain |
|
104
|
270
|
6a6pA |
Crystal structure of peroxisome proliferator-activated receptor delta (ppard)lbd in complex with dn003316 |
|
79
|
251
|
4ummF |
The cryo-em structure of the palindromic dna-bound usp-ecr nuclear receptor reveals an asymmetric organization with allosteric domain positioning |
|
89
|
243
|
4ummG |
The cryo-em structure of the palindromic dna-bound usp-ecr nuclear receptor reveals an asymmetric organization with allosteric domain positioning |
|
84
|
385
|
4nqaB |
Crystal structure of liganded hrxr-alpha/hlxr-beta heterodimer on dna |
|
83
|
329
|
4nqaA |
Crystal structure of liganded hrxr-alpha/hlxr-beta heterodimer on dna |
|
97
|
320
|
4iqrA |
Multi-domain organization of the hnf4alpha nuclear receptor complex on dna |
|
111
|
371
|
3e00D |
Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with gw9662, 9-cis retinoic acid and ncoa2 peptide |
|
79
|
324
|
3e00A |
Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with gw9662, 9-cis retinoic acid and ncoa2 peptide |
|
91
|
324
|
3dzuA |
Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with bvt.13, 9-cis retinoic acid and ncoa2 peptide |
|
83
|
324
|
3dzyA |
Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with rosiglitazone, 9-cis retinoic acid and ncoa2 peptide |
|
102
|
370
|
3dzyD |
Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with rosiglitazone, 9-cis retinoic acid and ncoa2 peptide |
|
104
|
370
|
3dzuD |
Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with bvt.13, 9-cis retinoic acid and ncoa2 peptide |
|
106
|
271
|
5z6sA |
Crystal structure of the ppargamma-lbd complexed with compound ds-6930 |
|
90
|
230
|
5za1A |
Ligand complex of rorgt lbd |
|
82
|
230
|
6a5yD |
Crystal structure of human fxr/rxr-lbd heterodimer bound to hnc143 and 9cra and src1 |
|
91
|
228
|
5y1jA |
Crystal structure of human fxr in complex with a functional drug ligand |
|
101
|
269
|
6ad9A |
Crystal structure of ppargamma ligand binding domain in complex with dibenzooxepine derivative compound-9 |
